Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse - Concepedia

Concepedia

Publication | Open Access

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

DOI Full Paper Access

104

Citations

21

References

2009

Year

Christoph Kahlert, H. Weber, Carolin Mogler, Frank Bergmann, Peter Schirmacher, Hannes Kenngott, Uwe Matterne, Nathan M. Mollberg, Nuh N. Rahbari, Ulf Hinz,

British Journal of Cancer

Abstract

Our findings support the hypothesis that the disruption of ALCAM-mediated adhesiveness is a relevant step in pancreatic cancer progression. Moreover, ALCAM overexpression is a relevant independent prognostic marker for poor survival and early tumour relapse in pancreatic cancer.

References

	Year	Citations

Page 1